Join
Live feed
·
PRReleasevia Quantisnow
Entera Bio Ltd. logo

Entera Announces First Quarter 2026 Financial Results and Updates Across its Oral Peptide Programs

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ENTX (Entera Bio Ltd.) and more on Quantisnow.